Cardio Diagnostics Holdings, Inc.
CDIO
$0.402
-$0.004-0.99%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 181.10% | 1,348.15% | 3,190.00% | 1,600.00% | 1,311.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 181.10% | 1,348.15% | 3,190.00% | 1,600.00% | 1,311.11% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 181.10% | 1,348.15% | 3,190.00% | 1,600.00% | 1,311.11% |
| SG&A Expenses | 5.98% | 9.76% | 64.05% | 57.92% | 230.31% |
| Depreciation & Amortization | 4.35% | 9.09% | 14.29% | 20.00% | 15.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.15% | 8.70% | 61.63% | 59.57% | 242.50% |
| Operating Income | -3.87% | -8.24% | -61.11% | -59.22% | -242.09% |
| Income Before Tax | 11.88% | -2.19% | -112.97% | -79.72% | -278.58% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.88% | -2.19% | -112.97% | -79.72% | -278.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.88% | -2.19% | -112.97% | -79.72% | -278.58% |
| EBIT | -3.87% | -8.24% | -61.11% | -59.22% | -242.09% |
| EBITDA | -1.41% | -5.76% | -59.31% | -57.32% | -242.13% |
| EPS Basic | 57.81% | 47.04% | -20.14% | -13.68% | -68.33% |
| Normalized Basic EPS | 53.94% | 41.23% | -21.55% | -17.56% | -70.98% |
| EPS Diluted | 57.81% | 47.04% | -20.14% | -13.68% | -68.33% |
| Normalized Diluted EPS | 53.94% | 41.23% | -21.55% | -17.56% | -70.98% |
| Average Basic Shares Outstanding | 111.49% | 107.72% | 100.12% | 96.72% | 134.35% |
| Average Diluted Shares Outstanding | 111.49% | 107.72% | 100.12% | 96.72% | 134.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
